Managing an acutely ill patient with pulmonary arterial hypertension

scientific article published on February 2013

Managing an acutely ill patient with pulmonary arterial hypertension is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1586/ERS.12.73
P698PubMed publication ID23362817

P2093author name stringNamita Sood
P2860cites workDopamine and angiotensin as renal counterregulatory systems controlling sodium balanceQ24609255
The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized pigletsQ24798087
Sildenafil ameliorates effects of inhaled nitric oxide withdrawalQ28369728
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008Q29615602
Primary pulmonary hypertension. A national prospective studyQ33169642
Blade balloon atrial septostomy in patients with severe primary pulmonary hypertensionQ33173560
Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trialQ33870278
Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.Q34025278
A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patientsQ34168150
Sildenafil citrate therapy for pulmonary arterial hypertensionQ34562650
Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and managementQ35013635
Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature reviewQ35559191
Management strategies for patients with pulmonary hypertension in the intensive care unitQ36940493
Prostacyclin therapies for the treatment of pulmonary arterial hypertensionQ37124222
Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effectsQ37611300
Right ventricular adaptation to pressure overloadQ37697461
Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertensionQ37703761
Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.Q37767429
Intensive care unit management of patients with severe pulmonary hypertension and right heart failureQ37893845
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).Q38372331
Nebulized milrinone use in a pulmonary hypertensive crisis.Q39327044
Changes in the pressure-volume relation of the right ventricle when its loading conditions are modifiedQ39520038
Bridge to lung transplantation through a pulmonary artery to left atrial oxygenator circuitQ40111846
Ventricular interdependence: significant left ventricular contributions to right ventricular systolic functionQ41693575
Superiority of levosimendan over dobutamine in right ventricle failureQ43214362
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.Q43246249
Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.Q43942580
Tricuspid annular displacement predicts survival in pulmonary hypertensionQ44026625
Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertensionQ44136363
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialQ44240810
Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failureQ44835431
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertensionQ44938984
Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenolQ44998521
Renal Vasodilatory Action of Dopamine in Patients With Heart Failure: Magnitude of Effect and Site of ActionQ46042709
Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot studyQ46266893
Selective pulmonary vasodilation with inhaled aerosolized milrinone in heart transplant candidatesQ46834789
Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantationQ48342765
Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertensionQ48579649
Poor outcomes associated with drainage of pericardial effusions in patients with pulmonary arterial hypertension.Q50778493
Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.Q51377220
Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.Q51501453
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension.Q51688048
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.Q51729165
Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.Q52422731
Bridge to Thoracic Organ Transplantation in Patients with Pulmonary Arterial Hypertension Using a Pumpless Lung Assist DeviceQ57824177
A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertensionQ57824432
P433issue1
P304page(s)77-83
P577publication date2013-02-01
P1433published inExpert Review of Respiratory MedicineQ15754583
P1476titleManaging an acutely ill patient with pulmonary arterial hypertension
P478volume7

Search more.